Maravai LifeSciences guides 2025 revenue $185M-$205M; Q1 revenue $43M-$45M

MARAVAI LIFESCIENCES HOLDINGS, INC.

Full-year 2025 revenue guidance $185M-$205M; Q1 2025 revenue $43M-$45M.
Adjusted EBITDA excludes interest ($14-16M), D&A ($50-55M), stock-based comp ($45-50M).
Fully diluted shares ~256M; capex expected $15M-$20M in 2025.
Guidance excludes impact of potential new acquisitions or unquantified items.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.